<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03094481</url>
  </required_header>
  <id_info>
    <org_study_id>036-2016</org_study_id>
    <nct_id>NCT03094481</nct_id>
  </id_info>
  <brief_title>Interscalene vs. Superficial Cervical Block vs. Combination for Analgesia After Clavicle Fracture</brief_title>
  <official_title>Comparison of Interscalene vs. Superficial Cervical Block vs. Combination of Both Blocks for Analgesia After Operative Repair of Midshaft and Lateral Clavicle Fractures</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sunnybrook Health Sciences Centre</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sunnybrook Health Sciences Centre</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The optimal analgesic peripheral nerve block (or combinations thereof) are undefined for
      clavicle fractures, the most frequent fracture in the human population. This goal of this
      study is to determine whether interscalene block (ISB), superficial cervical plexus block
      (SCPB), or both provide the best analgesia for lateral and midshaft clavicular fractures,
      respectively.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Clavicle fractures are relatively common injuries that occur most often in young active males
      and elderly individuals. They are often a result of direct trauma to the shoulder, typically
      from a fall. Clavicle fractures represent 5-10% of all fractures and represent the most
      frequent fracture in the human population. Midshaft fractures account for 69-85% of the
      clavicle fractures, distal shaft fractures 12-28%. (1) Analgesia for clavicle fractures can
      be challenging for anaesthetists secondary to the complex and varied innervation in this
      region. Literature describing the innervation of the clavicle and overlying skin is
      heterogeneous with the C3 to C6 nerve roots being involved. The clavicle itself has been
      reported to be innervated either by C4 or by C5 and C6 (subclavian nerve) nerve roots. (2)
      Regional anaesthesia for intraoperative and postoperative analgesia of clavicle fractures
      employs several possible, commonly used approaches. The contemporary literature surrounding
      the optimal regional anaesthetic technique for clavicle surgery which can provide superior
      postoperative analgesia and minimize systemic agents intraoperatively is lacking Currently
      there are only small case series or case reports published. Peripheral nerve blocks used to
      anesthetize the clavicle include SCPB, ISB, and combined SCPB-ISB. Larger, systematic trials
      have not yet been performed to our knowledge and as recently as one year ago a call for more
      evidence in this area of regional anaesthesia was published in the American Society of
      Regional Anesthesia and Pain Medicine. The purpose of this study is to compare analgesic
      outcomes after the common regional anesthetic techniques (ISB versus SCPB versus both).
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 21, 2016</start_date>
  <completion_date type="Anticipated">March 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">November 1, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
    <masking_description>All parties will be blinded except for the specific anesthesiologist performing the nerve blocks. This person will not be involved in providing further care (administering anesthesia) nor data collection.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Pain measurement using NRS in PACU</measure>
    <time_frame>1 hour post-op</time_frame>
    <description>Numeric Rating Scale for Pain upon discharge from Post-anesthetic Care Unit</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain measurement using NRS at Discharge</measure>
    <time_frame>4 hours post-op</time_frame>
    <description>Numeric Rating Scale for Pain upon discharge from hospital</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Opioid consumption in morphine equivalence</measure>
    <time_frame>4 hours post-op</time_frame>
    <description>Total postoperative opioid consumption from end of operation to hospital discharge</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Satisfaction using rating scale</measure>
    <time_frame>4 hours post-op</time_frame>
    <description>Patient satisfaction with postoperative analgesia at time of discharge</description>
  </secondary_outcome>
  <number_of_arms>6</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Clavicle Fracture</condition>
  <arm_group>
    <arm_group_label>US guided SCPB medial fracture</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Bupivacaine hydrogen chloride Inj 0.5% (1:200,000) epinephrine. 10ml injected for ultrasound guided Superficial Cervical Plexus Block at C4 or C5.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>US guided ISB medial fracture</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Bupivacaine hydrogen chloride Inj 0.5%(1:200,000) epinephrine. 10ml injected for ultrasound guided Interscalene Brachial Plexus Block at C5 or C6.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>US guided SCPB + ISB medial fracture</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Bupivacaine hydrogen chloride Inj 0.5% (1:200,000) epinephrine. 10ml injected for ultrasound guided Superficial Cervical Plexus Block at C4 or C5. 10ml injected for ultrasound guided Interscalene Brachial Plexus Block at C5 or C6.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>US guided SCPB lateral fracture</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Bupivacaine hydrogen chloride Inj 0.5% (1:200,000) epinephrine. 10ml injected for ultrasound guided Superficial Cervical Plexus Block at C4 or C5.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>US guided ISB lateral fracture</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Bupivacaine hydrogen chloride Inj 0.5%(1:200,000) epinephrine. 10ml injected for ultrasound guided Interscalene Brachial Plexus Block at C5 or C6.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>US guided SCPB + ISB lateral fracture</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Bupivacaine hydrogen chloride Inj 0.5% (1:200,000) epinephrine. 10ml injected for ultrasound guided Superficial Cervical Plexus Block at C4 or C5. 10ml injected for ultrasound guided Interscalene Brachial Plexus Block at C5 or C6.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>SCPB</intervention_name>
    <description>Bupivacaine hydrogen chloride Inj 0.5% epinephrine. 10ml injected for US guided Superficial Cervical Plexus Block at C4 or C5.</description>
    <arm_group_label>US guided SCPB medial fracture</arm_group_label>
    <arm_group_label>US guided SCPB lateral fracture</arm_group_label>
    <other_name>Superficial Cervical Plexus</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>ISB</intervention_name>
    <description>Bupivacaine hydrogen chloride Inj 0.5% epinephrine. 10ml injected for US guided Interscalene Brachial Plexus Block at C5 or C6.</description>
    <arm_group_label>US guided ISB medial fracture</arm_group_label>
    <arm_group_label>US guided ISB lateral fracture</arm_group_label>
    <other_name>Interscalene Brachial Plexus</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>SCPB + ISB</intervention_name>
    <description>Bupivacaine hydrogen chloride Inj 0.5% epinephrine. 10ml injected for US guided SCPB at C4 or C5 + 10ml injected for ISB at C5 or C6.</description>
    <arm_group_label>US guided SCPB + ISB medial fracture</arm_group_label>
    <arm_group_label>US guided SCPB + ISB lateral fracture</arm_group_label>
    <other_name>Superficial Cervical Plexus &amp; Interscalene Brachial Plexus</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupivacaine hydrogen chloride , epinephrine</intervention_name>
    <description>Bupivacaine hydrogen chloride Inj 0.5% (1:200,000) epinephrine</description>
    <arm_group_label>US guided SCPB medial fracture</arm_group_label>
    <arm_group_label>US guided ISB medial fracture</arm_group_label>
    <arm_group_label>US guided SCPB + ISB medial fracture</arm_group_label>
    <arm_group_label>US guided SCPB lateral fracture</arm_group_label>
    <arm_group_label>US guided ISB lateral fracture</arm_group_label>
    <arm_group_label>US guided SCPB + ISB lateral fracture</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  undergoing open reduction and internal fixation of clavicle fracture (midshaft or
             lateral)

        Exclusion Criteria:

          -  lack of patient consent

          -  contra-indication to upper extremity peripheral nerve block (eg. severe pulmonary
             dysfunction)

          -  inability to lie supine for nerve block

          -  polytrauma

          -  pre-existing neurologic deficit in operative upper extremity

          -  allergy to amide local anesthetic

          -  contralateral phrenic nerve dysfunction

          -  chronic opioid use (&gt;30mg daily oral morphine equivalent)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Paul McHardy, MD, FRCPC</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sunnybrook Health Sciences Centre</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Paul McHardy, MD, FRCPC</last_name>
    <phone>4164804864</phone>
    <email>paul.mchardy@sunnybrook.ca</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Shelly Au, PhD, PMP</last_name>
    <phone>4164806100</phone>
    <phone_ext>89607</phone_ext>
    <email>shelly.au@sunnybrook.ca</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Sunnybrook Health Sciences Centre</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M4N 3M5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paul McHardy, MD</last_name>
      <phone>416-480-6100</phone>
      <phone_ext>pg x 6626</phone_ext>
      <email>paul.mchardy@sunnybrook.ca</email>
    </contact>
    <investigator>
      <last_name>Paul McHardy, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Stephen Choi, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Patrick Henry, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <reference>
    <citation>Faldini C, Nanni M, Leonetti D, Acri F, Galante C, Luciani D, Giannini S. Nonoperative treatment of closed displaced midshaft clavicle fractures. J Orthop Traumatol. 2010 Dec;11(4):229-36. doi: 10.1007/s10195-010-0113-z. Epub 2010 Oct 9.</citation>
    <PMID>20936323</PMID>
  </reference>
  <reference>
    <citation>Choi DS, Atchabahian A, Brown AR. Cervical plexus block provides postoperative analgesia after clavicle surgery. Anesth Analg. 2005 May;100(5):1542-3.</citation>
    <PMID>15845732</PMID>
  </reference>
  <reference>
    <citation>Tran DQ, Tiyaprasertkul W, Gonz√°lez AP. Analgesia for clavicular fracture and surgery: a call for evidence. Reg Anesth Pain Med. 2013 Nov-Dec;38(6):539-43. doi: 10.1097/AAP.0000000000000012.</citation>
    <PMID>24121609</PMID>
  </reference>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 15, 2017</study_first_submitted>
  <study_first_submitted_qc>March 28, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">March 29, 2017</study_first_posted>
  <last_update_submitted>May 2, 2018</last_update_submitted>
  <last_update_submitted_qc>May 2, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 3, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sunnybrook Health Sciences Centre</investigator_affiliation>
    <investigator_full_name>Dr. Paul McHardy</investigator_full_name>
    <investigator_title>Assistant Professor, Staff Anesthesiologist</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fractures, Bone</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bupivacaine</mesh_term>
    <mesh_term>Epinephrine</mesh_term>
    <mesh_term>Racepinephrine</mesh_term>
    <mesh_term>Epinephryl borate</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

